Schedule of Warrant Outstanding Issued Exercised and Expired (Details) - shares |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2026 |
Dec. 31, 2025 |
|
| Equity [Abstract] | ||
| Number of warrants outstaning, Balance | 351,528 | |
| Weighted average exercise price, Balance | 4.75 | |
| Expiration date | 2029 | 2029 |
| Number of warrants, Issued | ||
| Number of warrants, Exercised | ||
| Number of warrants, Expired | ||
| Number of warrants outstaning, Balance | 351,528 | 351,528 |
| Weighted average exercise price, Balance | 4.75 | 4.75 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Warrants expiration term. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|